Eight-week Effect of the Sit-to-stand Test on Muscle Architecture.
NCT ID: NCT05469191
Last Updated: 2023-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-08-08
2023-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
H1: 10 STS significantly modifies vastus lateralis muscle architecture in adults compared to 5STS and the control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relation Between Rectus Femoris Muscle Tension and Hamstring Strength and Activity in Healthy Sprinters
NCT04344691
Acute Effects of Squat Protocols in Muscular Power, Postural Sway and Tendinous Thickness.
NCT03929380
Comparison of Eccentric Exercise and Static Stretching on Muscle Flexibility
NCT06469346
The Effect of Power Posing on Timed Up and Go Test Score
NCT03032393
Motor Imagery and Muscle Architecture
NCT05558033
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 5 STS
Group 5 STS will perform the same protocol as group 10 STS, only the number of repetitions between each set will change.
Group 5 STS
For 8 weeks, 3 times per week and 3 sets of 5 repetitions during the first month, then 5 sets of 5 repetitions during the second month.
Between each repetition, there will be a rest of 30 to 60 seconds approximately.
Group 10 STS
Group 10 STS will perform the same protocol as group 5 STS, only the number of repetitions between each set will change.
Group 10 STS
For 8 weeks, 3 times per week and 3 sets of 10 repetitions during the first month, then 5 sets of 10 repetitions during the second month.
Between each repetition, there will be a rest of 30 to 60 seconds approximately.
Control group
Control group, no intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 5 STS
For 8 weeks, 3 times per week and 3 sets of 5 repetitions during the first month, then 5 sets of 5 repetitions during the second month.
Between each repetition, there will be a rest of 30 to 60 seconds approximately.
Group 10 STS
For 8 weeks, 3 times per week and 3 sets of 10 repetitions during the first month, then 5 sets of 10 repetitions during the second month.
Between each repetition, there will be a rest of 30 to 60 seconds approximately.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* They must have signed the informed consent form.
* Who can perform the STS.
* In case of suffering from a chronic non-communicable disease, that it is under control.
Exclusion Criteria
* Hypertension (\>200/110 mmHg).
* Acute neuromuscular or joint injury.
* Who have suffered a stroke in the last 6 months.
* Who have suffered a myocardial infarction or fracture in the last 6 months.
* Terminally ill.
* People who practice a sport professionally.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rodrigo Lizama Perez
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rodrigo Lizama Pérez, M.Sc
Role: PRINCIPAL_INVESTIGATOR
Universidad de Granada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad San Sebastián, sede Valdivia.
Valdivia, , Chile
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDAFISAD 64201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.